Bimanual Motor Skill Learning Through Robotics in Stroke Survivors and Healthy Individuals (bimMsKL)

March 31, 2025 updated by: Pr Yves Vandermeeren, MD, PhD, University Hospital of Mont-Godinne
To test the capacity of healthy and chronic stroke patients to learn and retain a complex bimanual motor skill, trained on the neurorehabilitation robot REAplan (R) (bimanual version).

Study Overview

Detailed Description

Over 3 consecutive days, healthy individuals and chronic stroke patients (1) will be evaluated and (2) will train on the neurorehabilitation robot REAplan(R).

They will practice several tasks on the robot REAplan (R) (bimanual version), requiring either movements with the affected arm (unimanual tasks) and complex, coordinated movements with both arms (bimanual tasks).

In addition, several "classical" clinical scales and tests will be used to evaluate overall motor-sensory-cognitive functions (clinical tests, questionnaires, ...).

Study Type

Interventional

Enrollment (Estimated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Namur
      • Yvoir, Namur, Belgium, 5530
        • Recruiting
        • CHU UCL Namur, Mont-Godinne, Neurology Department, Stroke Unit
        • Contact:
        • Contact:
          • Mie Leeuwerck, PT
        • Contact:
          • Audrey Riga, MSc
        • Contact:
          • Damien Bontemps, student
        • Contact:
          • Nicolas-Thomas Babuin, student
      • Yvoir, Namur, Belgium
        • Recruiting
        • Department of Neurology, CHU Mont-Godinne
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 86 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

STROKE PATIENTS :

Inclusion Criteria:

  • having a chronic stroke (>6 months)
  • aged 18-90 years
  • with demonstrate a stroke lesion on brain imaging.

Exclusion Criteria:

  • difficulty in understanding or executing commands
  • drug/alcohol abuse
  • severe aphasia / cognitive deficits interfering with study
  • inability to voluntarily move the affected arm (i.e. complete paralysis of the arm)
  • multiple strokes / dementia / psychiatric condition
  • botulinum toxin injections (to be evaluated)

HEALTHY INDIVIDUALS :

Inclusion Criteria:

- 18-90 years

Exclusion Criteria:

  • neurological conditions interfering with the study
  • drug/alcohol abuse
  • pyschiatric condition

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intervention
Training on the rehabilitation robot REAplan(R) to learn complex, coordinated bimanual movements
REAplan(R) rehabilitation robot : training to perform complex, coordinated, bimanual movements
Active Comparator: control intervention
Training on the rehabilitation robot REAplan(R) with simple movements
REAplan(R) rehabilitation robot : training to perform complex, coordinated, bimanual movements

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
bi-SAT, bimanual Speed/Accurady Trade-off measured by the REAplan robot
Time Frame: change between baseline (Day 1) and after training (Day 3)
bimanual Speed/Accurady Trade-off: mathematical computation of the relationship bewteen speed and accuracy
change between baseline (Day 1) and after training (Day 3)
bi-CO, bimanual Coordination factor measured by the REAplan robot
Time Frame: change between baseline (Day 1) and after training (Day 3)
bimanual Coordination factor, mathematical measure of the phase coherence between speeds of both arms
change between baseline (Day 1) and after training (Day 3)
bi-Force, bimanual Coordination factor measured by the REAplan robot
Time Frame: change between baseline (Day 1) and after training (Day 3)
bimanual forces, forces exerted in the wrong direction by each arm (Newtons)
change between baseline (Day 1) and after training (Day 3)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
bi-SAT on bimanual REACHING (REAplan robot)
Time Frame: change between baseline (Day 1) and after training (Day 3)
bimanual Speed/Accurady Trade-off: mathematical computation of the relationship
change between baseline (Day 1) and after training (Day 3)
bi-Force on bimanual REACHING (REAplan robot)
Time Frame: change between baseline (Day 1) and after training (Day 3)
bimanual forces, forces exerted in the wrong direction by each arm (Newtons)
change between baseline (Day 1) and after training (Day 3)
bi-CO on bimanual REACHING (REAplan robot)
Time Frame: change between baseline (Day 1) and after training (Day 3)
bimanual Coordination factor, mathematical measure of the phase coherence between speeds of both arms
change between baseline (Day 1) and after training (Day 3)
bi-smoothness on bimanual REACHING (REAplan robot)
Time Frame: change between baseline (Day 1) and after training (Day 3)
Smoothness of movement : Spectral Arc Length (SPARC)
change between baseline (Day 1) and after training (Day 3)
bi-error on bimanual REACHING (REAplan robot)
Time Frame: change between baseline (Day 1) and after training (Day 3)
Error in centimeres or degrees during bimanual reaching
change between baseline (Day 1) and after training (Day 3)
BBT
Time Frame: change between baseline (Day 1) and after training (Day 3)
Box & Blocks Test (timed transfert of blocks from one space to the other, 3 trials/hand)
change between baseline (Day 1) and after training (Day 3)
whole-hand GF
Time Frame: change between baseline (Day 1) and after training (Day 3)
whole-hand Grip Force (GF) measured with a dynamometer, 3 trials/hand)
change between baseline (Day 1) and after training (Day 3)
Visual Analog Scale for fatigue (VAS fatigue)
Time Frame: change between baseline (Day 1) and after training (Day 3)
Visual Analog Scale to evaluate fatigue = a psychometric response scale which can be used in questionnaires. It is a measurement instrument for subjective characteristics or attitudes that cannot be directly measured. When responding to a VAS item, respondents specify their level of agreement to a statement by indicating a position along a continuous line between two end-points. Range : 0- 10.
change between baseline (Day 1) and after training (Day 3)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Yves Y Vandermeeren, MD, PhD, Université catholique de Louvain, Institute of NeuroScience (IONS) NEUR / CHU

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2017

Primary Completion (Estimated)

December 31, 2030

Study Completion (Estimated)

December 31, 2030

Study Registration Dates

First Submitted

May 28, 2019

First Submitted That Met QC Criteria

June 3, 2019

First Posted (Actual)

June 5, 2019

Study Record Updates

Last Update Posted (Actual)

April 3, 2025

Last Update Submitted That Met QC Criteria

March 31, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

the precise IPD plan has to be worked out in order to find the best public repository

IPD Sharing Time Frame

Up to 2 years after publication of the scientific articles

IPD Sharing Access Criteria

none (public)

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Bimanual motor skill learning with the REAplan(R) rehabilitation robot

Subscribe